People

MannKind Corporation has appointed Matthew J. Pfeffer as CEO effective January 10, 2016, replacing Alfred Mann. In November 2015, Mann temporarily resumed his role as CEO after Hakan Edstrom stepped down. On January 5, 2016, MannKind announced that Sanofi would return the rights to its Afrezza inhaled insulin and that it was considering options for the product. … [Read more...] about MannKind appoints Matthew J. Pfeffer as CEO

After the arrest of its CEO, Martin Shkreli, on securities fraud charges, Turing Pharmaceuticals has announced Shkreli's resignation and the appointment of Ron Tilles as Interim CEO. Tilles has chaired Turing's board of directors since the company's inception. Turing launched in 2014 after Shkreli's former employer Retrophin ousted him over alleged stock trading … [Read more...] about Turing Pharmaceuticals names Ron Tilles interim CEO

Dry powder inhalation products developer Pulmatrix has appointed former Civitas Therapeutics CEO Mark Iwicki as chairman of its board of directors, the company said. Iwicki has also previously headed Blend Pharmaceuticals and Sunovion and currently sits on the boards of directors of Kala Pharmaceuticals, Aimmune, Nimbus Therapeutics, Merus and Taris … [Read more...] about Mark Iwicki appointed Pulmatrix board chairman

MannKind Corporation has announced the resignation of Hakan Edstrom, who was the company's President and CEO, as well as a director. In the wake of the resignation, Alfred Mann has been appointed interim CEO, effective November 19, 2015, and a board committee has begun a search for a new CEO. Edstrom took over as CEO from Mann in January 2015, prior to Sanofi's … [Read more...] about Hakan Edstrom steps down as CEO of MannKind Corporation

Hovione has announced that Kristine Senft has joined the company as VP, Sales and Marketing and will succeed Dave Hoffman as VP, Sales and Business Development upon his retirement in April 2016. Senft, who was most recently VP, Regenerative Materials at DSM Biomedical, will be based in New Jersey, where Hovione recently announced that it would be doubling the size of … [Read more...] about Kristine Senft appointed VP Sales & Marketing at Hovione

Alexza Pharmaceuticals has promoted Catherine McAuliffe to VP, Operations and Stacy Palermini to VP, Finance, the company said. McAuliffe most recently served as Executive Director, Operations; the position of VP, Operations is newly created. Palermini was previously Executive Director, Finance. Alexza is developing several products using its Staccato inhalation … [Read more...] about Alexza Pharmaceuticals announces two promotions

Insys Therapeutics has announced that it will partner with Senzer Ltd, a subsidiary of Kind Consumer, to develop inhaled dronabinol (THC) and cannabidiol (CBD) products. Insys has licensed Senzer's delivery technology, the same technology in the Voke nicotine inhaler, which was approved in the UK in September 2014. Senzer CEO and Kind Consumer founder Alex Hearn … [Read more...] about Insys to develop inhaled cannabinoids using Voke inhaler technology, hires OINDP specialists

Cirrus Pharmaceuticals announced that it has hired Andrew Hamer as VP R&D. Hamer was most recently Senior Director of R&D Operations at GSK's dermatology subsidiary Stiefel. He also has experience in OINDP development at Cardinal, Sanofi, and Covance. Cirrus, based in Research Triangle Park, NC, was acquired by Kemwell in 2013. It offers inhalation and nasal … [Read more...] about Cirrus Pharmaceuticals hires Andrew Hamer as VP R&D